Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score.
Saved in:
| Title: | Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score. |
|---|---|
| Authors: | Taha HF; Medical Oncology Department, Zagazig University, Zagazig, Egypt., Elsayed DH; Medical Oncology Department, Zagazig University, Zagazig, Egypt., Salem R; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt., Mandour D; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt., Bayomy M; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt., Rashed H; Pathology Department, Zagazig University, Zagazig, Egypt., Kamel M; Urology Department, Zagazig University, Zagazig, Egypt., Elderey M; Urology Department, Zagazig University, Zagazig, Egypt., Elfarargy OM; Medical Oncology Department, Zagazig University, Zagazig, Egypt. |
| Source: | Contemporary oncology (Poznan, Poland) [Contemp Oncol (Pozn)] 2022; Vol. 26 (3), pp. 196-203. Date of Electronic Publication: 2022 Oct 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Termedia Country of Publication: Poland NLM ID: 101233223 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1428-2526 (Print) Linking ISSN: 14282526 NLM ISO Abbreviation: Contemp Oncol (Pozn) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36381673 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Taha+HF%22">Taha HF</searchLink>; Medical Oncology Department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Elsayed+DH%22">Elsayed DH</searchLink>; Medical Oncology Department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Salem+R%22">Salem R</searchLink>; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Mandour+D%22">Mandour D</searchLink>; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Bayomy+M%22">Bayomy M</searchLink>; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Rashed+H%22">Rashed H</searchLink>; Pathology Department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Kamel+M%22">Kamel M</searchLink>; Urology Department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Elderey+M%22">Elderey M</searchLink>; Urology Department, Zagazig University, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Elfarargy+OM%22">Elfarargy OM</searchLink>; Medical Oncology Department, Zagazig University, Zagazig, Egypt. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101233223%22">Contemporary oncology (Poznan, Poland)</searchLink> [Contemp Oncol (Pozn)] 2022; Vol. 26 (3), pp. 196-203. <i>Date of Electronic Publication: </i>2022 Oct 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Termedia%22">Termedia </searchLink><i>Country of Publication: </i>Poland <i>NLM ID: </i>101233223 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1428-2526 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214282526%22">14282526 </searchLink><i>NLM ISO Abbreviation: </i>Contemp Oncol (Pozn) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36381673 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.5114/wo.2022.120592 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 196 Titles: – TitleFull: Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Taha HF – PersonEntity: Name: NameFull: Elsayed DH – PersonEntity: Name: NameFull: Salem R – PersonEntity: Name: NameFull: Mandour D – PersonEntity: Name: NameFull: Bayomy M – PersonEntity: Name: NameFull: Rashed H – PersonEntity: Name: NameFull: Kamel M – PersonEntity: Name: NameFull: Elderey M – PersonEntity: Name: NameFull: Elfarargy OM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1428-2526 Numbering: – Type: volume Value: 26 – Type: issue Value: 3 Titles: – TitleFull: Contemporary oncology (Poznan, Poland) Type: main |
| ResultId | 1 |
